Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer
Clinical trial NCT05859477 · UNKNOWN
Trial details
- NCT number
- NCT05859477
- Sponsor
- Kidney Cancer Research Bureau
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-05
- Primary completion
- 2023-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.